renal disease

Roche pens $2B deal with Atavistik to discover new CVRM drugs

Roche has penned a backloaded $2 billion deal with hematology biotech Atavistik Bio to develop allosteric small molecules for cardiometabolic diseases.

James Waldron Sep 24, 2026 8:35am

AstraZeneca pays CSPC $30M to form kidney drug discovery pact

Jul 3, 2026 8:00am

A pair of kidneys and diagnostic tools such as a microscope and beakers

Quest Diagnostics to claim Fresenius’ dialysis testing portfolio

Feb 26, 2025 11:00am

eGenesis announces 2nd pig kidney transplant success

Feb 7, 2025 2:10pm

Pfizer and Flagship add Quotient to multibillion-dollar equation

Aug 28, 2024 6:30am

A graphic displaying a cross-section of the kidneys

Revivicor sees 61 days' function in kidney+thymus xenotransplant

Sep 25, 2023 9:45am